Pharnext (PNEXF) News Today $400.00 0.00 (0.00%) (As of 07/13/2023) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Pharnext (OTCMKTS:PNEXF) Trading Up 399,999,900% - Still a Buy?November 26 at 2:36 AM | americanbankingnews.comPharnext SA PNEXFAugust 2, 2024 | morningstar.comPHARNEXT: Pharnext takes full stock of its operating, strategic and financial situationMarch 11, 2024 | finanznachrichten.dePharnext progresses in analyzing data from pivotal Phase III study of PXT3003 in Charcot-Marie-Tooth disease type 1AFebruary 28, 2024 | actusnews.comPHARNEXT by Pharnext Stock (OTC:PNEXF), Insider Trading ActivityFebruary 25, 2024 | benzinga.comPHARNEXT: Pharnext commits to a drastic cost-cutting plan to further enhance the value of its drug candidate for Charcot-Marie-Tooth disease type 1AJanuary 17, 2024 | finanznachrichten.dePharnext commits to a drastic cost-cutting plan to further enhance the value of its drug candidate for Charcot-Marie-Tooth disease type 1AJanuary 17, 2024 | actusnews.comPharnext set to release pivotal trial data for CMT1A treatment PXT3003December 15, 2023 | investing.comPharnext SA ALPHADecember 2, 2023 | morningstar.comPHARNEXT: Pharnext announces successful manufacturing of registration batches of PXT3003 in the United StatesNovember 20, 2023 | finanznachrichten.dePharnext announces successful manufacturing of registration batches of PXT3003 in the United StatesNovember 20, 2023 | actusnews.comPharnext received two offers valuing its drug candidate for Charcot-Marie-Tooth disease type 1A at more than EUR 250m, and raises EUR 2.5mOctober 16, 2023 | actusnews.comPharnext updates on the development program in China for PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A)September 28, 2023 | actusnews.comPHARNEXT: Pharnext shareholders approve the appointment of Guy-Charles Fanneau de La Horie to the Supervisory BoardJuly 10, 2023 | finanznachrichten.dePharnext shareholders approve the appointment of Guy-Charles Fanneau de La Horie to the Supervisory BoardJuly 10, 2023 | actusnews.comPharnext appoints Gilbert Wagener, M.D., Ph.D. as Chief Medical OfficerJune 15, 2023 | actusnews.comPharnext supports and participates in the First European Charcot-Marie-Tooth disease Specialists ConferenceJune 8, 2023 | actusnews.comPHARNEXT: Edison Investment Research publishes updates research report on PharnextMay 22, 2023 | finanznachrichten.dePHARNEXT: Pharnext supports the upcoming Spring Meeting of the Neuromuscular Diseases Study Group of the Spanish Society of Neurology (SEN)May 12, 2023 | finanznachrichten.dePharnext supports the upcoming Spring Meeting of the Neuromuscular Diseases Study Group of the Spanish Society of Neurology (SEN)May 12, 2023 | actusnews.comGlobal Dental Partnering 2010-2023: Deal Trends, Players and FinancialsMay 5, 2023 | finance.yahoo.comPharnext supports the online 2023 Conference of CMTUK, the UK's Charity dedicated to supporting people living with Charcot-Marie-Tooth diseaseApril 18, 2023 | actusnews.comPHARNEXT: Pharnext supports and participates in two congresses on Neuromuscular Disorders in EuropeMarch 20, 2023 | finanznachrichten.dePharnext supports and participates in two congresses on Neuromuscular Disorders in EuropeMarch 20, 2023 | actusnews.comPharnext supports and participates in two congresses dedicated to Charcot-Marie-Tooth diseases in Marseille, FranceMarch 14, 2023 | actusnews.comPHARNEXT: Pharnext supports and participates in the 27th edition of the Francophone Peripheral Nerve Society conference (SFNP) in ParisMarch 6, 2023 | finanznachrichten.dePharnext SA (ALPHA.PA)February 15, 2023 | finance.yahoo.comPharnext unveils the latest progress of the PREMIER trial, pivotal Phase III clinical trial of PXT3003 in Charcot-Marie-Tooth disease type 1AFebruary 2, 2023 | actusnews.comPHARNEXT: Pharnext announces successful completion of manufacturing transfer and scale-up of PXT3003 in the United StatesJanuary 26, 2023 | finanznachrichten.dePHARNEXT: Pharnext supports and participates in the 21st King's College Symposium on Neuromuscular Diseases in LondonJanuary 25, 2023 | finanznachrichten.dePHARNEXT: Pharnext convenes its shareholders to approve a new legal and financial framework adapted to its missionJanuary 24, 2023 | finanznachrichten.dePHARNEXT: Agreement signed for the financing of Pharnext by NéovacsJanuary 19, 2023 | finanznachrichten.deSignature d'une convention encadrant le financement de Pharnext par NéovacsJanuary 19, 2023 | actusnews.comAgreement signed for the financing of Pharnext by NéovacsJanuary 19, 2023 | actusnews.comPHARNEXT: Shareholder Letter: "Time to reveal Pharnext true value"January 11, 2023 | finanznachrichten.deShareholder Letter: 'Time to reveal Pharnext true value'January 11, 2023 | actusnews.comPHARNEXT: Pharnext in discussions with investment research firm Edison to update valuation of assetsJanuary 5, 2023 | finanznachrichten.dePharnext in discussions with investment research firm Edison to update valuation of assetsJanuary 5, 2023 | actusnews.comPharnext strengthens its ties with Néovacs to -2-December 28, 2022 | finanznachrichten.dePharnext Strengthens its Ties With Néovacs to Secure the Next Steps in its DevelopmentDecember 28, 2022 | benzinga.comPharnext Reports First Half 2022 Financial ResultsOctober 17, 2022 | finance.yahoo.comPharnext appoints former Silence Therapeutics exec as CFOSeptember 2, 2022 | seekingalpha.comPharnext to raise €2.5M loan from French biotech NéovacsAugust 25, 2022 | seekingalpha.comPharnext Announces a EUR2.5m Loan Agreement with NéovacsAugust 24, 2022 | finanznachrichten.dePharnext Announces a €2.5m Loan Agreement with NéovacsAugust 23, 2022 | finance.yahoo.comPharnext Holds Shareholders Meeting and Appoints Dr. James Kuo to Renewed Board of DirectorsJuly 13, 2022 | ca.finance.yahoo.comPharnext Appoints Antoine Gravelle as General CounselJuly 5, 2022 | uk.finance.yahoo.comPharnext Announces Successful Debt Refinancing and New Loan AgreementJune 8, 2022 | uk.finance.yahoo.comPharnext: Pharnext Reports Full Year 2021 Financial Results and Recent Business UpdatesApril 25, 2022 | finanznachrichten.dePharnext: Pharnext Reports Full Year 2021 -2-April 25, 2022 | finanznachrichten.de Get Pharnext News Delivered to You Automatically Sign up to receive the latest news and ratings for PNEXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Your 401(k) vs. BRICS: The Battle for Your Financial Future (Ad)As Global Powers Plot the Dollar's Demise Your Retirement Hangs by a Thread While the mainstream media stays silent, a financial earthquake is brewing that could shake your retirement to its core. BRICS, the anti-Trump alliance under control of Vladimir Putin & the Russians, just invited 13 new nations to join their anti-dollar coalition. Think this doesn't affect you? Request Your FREE "US DOLLAR COLLAPSE" GUIDE Now PNEXF Media Mentions By Week PNEXF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PNEXF News Sentiment▼0.000.54▲Average Medical News Sentiment PNEXF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PNEXF Articles This Week▼10▲PNEXF Articles Average Week Get Pharnext News Delivered to You Automatically Sign up to receive the latest news and ratings for PNEXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Ascentage Pharma Group International News Today Ascletis Pharma News Today Avacta Group News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today BerGenBio ASA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PNEXF) was last updated on 11/26/2024 by MarketBeat.com Staff From Our PartnersYour 401(k) vs. BRICS: The Battle for Your Financial FutureAs Global Powers Plot the Dollar's Demise Your Retirement Hangs by a Thread While the mainstream media stay...American Hartford Gold | SponsoredJ.D. Vance: Wall Street Will Tank Bonds to Sabotage TrumpJ.D. Vance just dropped a bombshell: With Trump in office, Wall Street could drive the bond market into a deat...Golden Crest | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredFormer Trump advisor issues urgent warningElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharnext SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharnext With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PNEXF Stock Alerts